Efficacy of ibuprofen and pentoxifylline in the treatment of phosgene-induced acute lung injury

Journal of Applied Toxicology

Volumn 16, Issue 5, 1996, Pages 381-384

  Sciuto, Alfred M ^a   Stotts, Richard R ^a   Hurt, Holcombe H ^a  

^a U States Army Med Res Inst C   (United States)

Author keywords

Edema; Ibuprofen; Lung; Pentoxifylline; Toxic gas

Indexed keywords

IBUPROFEN; METHYLXANTHINE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PHOSGENE; TOXIC GAS;

ANIMAL MODEL; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG EDEMA; LUNG INJURY; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WAR;

ADMINISTRATION, INHALATION; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMICAL WARFARE AGENTS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; IBUPROFEN; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; ORGAN SIZE; PENTOXIFYLLINE; PHOSGENE; PHOSPHODIESTERASE INHIBITORS; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT;

ANIMALIA;

EID: 0029764799     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199609)16:5<381::AID-JAT355>3.0.CO;2-8     Document Type: Conference Paper

References (33)

1. T. P. Kennedy, J. R. Michael, J. Hoidal, D. Hasty, A. M. Sciuto, C. Hopkins, R. Lazar, G. Bysani and G. H. Gurtner, Dibutyryl cAMP, aminophylline and β-adrenergic agonists protect against pulmonary edema caused by phosgene. J. Appl. Physiol. 67(6), 2542-2552 (1989).
2. Y-L. Guo, T. P. Kennedy, J. R. Michael, A. M. Sciuto, A. J. Ghio, N. F. Adkinson and G. H. Gurtner, Mechanisms of phosgene-induced lung injury: role of arachidonate mediators. J. Appl. Physiol. 69(5), 1615-1622 (1990).
3. T. P. Kennedy, N. V. Rao, W. Noah, J. R. Michael, M. Jafri, G. H. Gurtner and J. R. Hoidal, Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J. Clin. Invest. 86, 1565-1573 (1990).
4. A. M. Sciuto, P. T. Strickland, T. P. Kennedy and G. H. Gurtner, Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am. J. Respir. Crit. Care Med. 151, 768-772 (1995).
5. W. F. Diller, Medical problems and their solutions. J. Occup. Med. 20(3), 189-193 (1978).
6. NIOSH, Criteria for a Recommended Standard: Occupational Exposure to Phosgene, USDEW, PHS, CDC publication no. 76137. NIOSH, Washington, DC (1976).
7. Mobay Chemical Company, 'Phosgene' - an Important Chemical, 9 pp. Mobay Chemical Co., (1988).
8. A. P. Polednak and D. R. Hollis, Mortality and cause of death among workers exposed to phosgene in 1943-45. Toxicol. Indust. Health 1(2), 137-151 (1985).
9. S. A. Cucinell, Review of the toxicity of long-term phosgene exposure. Arch. Environ. Health 28, 272-275 (1974).
10. NIOSH/OSHA, A Pocket Guide to Chemical Hazards, ed. by F. W. Mackison and R. S. Stricoff, Publication no. 78-210. US Department of Health, Education and Welfare, Washington, DC. (1980).
11. A. Ward and S. P. Clissold, Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34, 50-97 (1987).
12. H. Bessler, R. Gilgal, M. Djaldetti and I. Zahavi, Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J. Leukocyte Biol. 40, 747-754 (1986).
13. R. J. McDonald, Pentoxifylline reduces injury to isolated lungs perfused with human neutrophils. Am. Rev. Respir. Dis. 144, 1347-1350 (1991).
14. M. Coccia, K. Waxman, H. Soliman and G. Tominaga, Pentoxifylline improves survival following hemorrhagic shock. Crit. Care Med. 17(1), 36-38 (1989).
15. A. Ishizaka, J. R. Hatherill, H. Harada, M. Yonemaru, H. Hoffman, H. Zheng, P. T. O'Hanley and T. A. Raffin, Prevention of interleukin 2-induced acute lung injury in guinea pigs by pentoxifylline. J. Appl. Physiol. 67(6), 2432-2437 (1989).
16. C. H. Welsh, D. Lien, G. S. Worthen and J. V. Weil, Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. Am. Rev. Respir. Dis. 138, 1106-1114 (1988).
17. 2) by pentoxifylline from human vascular tissue. Arnzeimittelforschung 32, 1315-1318 (1982).
18. R. J. Stewart, K. T. Yamaguchi, P. M. Knost, S. W. Mason, B. B. Roshdieh, S. Samadani and B. L. Chang, Effects of ibuprofen on pulmonary oedema in an animal smoke model. Burns 16(6), 409-413 (1990).
19. L-C. Jin, C. Lalonde and R. H. Demling, Lung dysfunction after thermal injury in relation to prostanoid and oxygen radical release. J. Appl. Physiol. 61, 103-112 (1986).
20. 2α during paraquat-induced pulmonary edema in the perfused lung. Toxicol. Appl. Pharmacol. 70, 105-114 (1983).
21. Physician's Desk Reference, 42nd Edn. Edward R. Barnhart, Montuale, New Jersey (1988).
22. L. Ott, An Introduction to Statistical Methods and Data Analysis, 3rd Edn, Chapt. 10. PWS-Kent Publishing Co., Boston (1988).
23. A. B. Wells, Phosgene: a practitioner's point of view. Toxicol. Indust. Health 1(2), 81-92 (1985).
24. H. Babad and A. G. Zeiler, The chemistry of phosgene. Chem. Rev. 73(1), 75-91 (1973).
25. M. F. Frosolono and W. D. Currie, Response of the pulmonary surfactant system to phosgene. Toxicol. Indust. Health 1(2), 29-35 (1985).
26. P. Ade, C. Guastadisegni, E. Testai and L. Vittozzi, Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice. J. Biochem. Toxicol. 9(6), 289-295 (1994).
27. T. Nash and R. E. Pattle, The absorption of phosgene by aqueous solutions and its relation to toxicity. Ann. Occup. Hyg. 14, 227-233 (1971).
28. A. M. Sciuto, R. R. Stotts, V. Chittenden, E. Choung and M. D. Heflin, Spectrophotometric changes in absorbance at 412-415 nm in plasma from three rodent species exposed to phosgene (1995). Biochem, Biophysical Research Communications, May 1996.
29. G. M. Lilly, J. S. Sandhu, A. Ishizaka, H. Harada, M. Yonemaru, J. Larrick, T-X. Shi, P. T. O'Hanley and T. Raffin, Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am. Rev. Respir. Dis. 139, 1361-1368 (1989).
30. H-I. Lin, K. Hsu, H-C. Yan and C-Y. Shen, Protective effect of pentoxifylline on phorbol myristate acetate-induced acute lung injury in rats. J. Formosan Med. Assoc. 89(9), 742-748 (1990).
31. B. A. Teicher, S. A. Holden, T. S. Herman, R. Epelbaum, A. B. Pardee and B. Dezube, Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res. 11, 1555-1560 (1991).
32. A. M. Sciuto, Y-L. Guo, T. P. Kennedy, J. R. Michael and G. H. Gurtner, Drugs that increase cyclic AMP attenuate phosgene-induced lung injury. Am. Rev. Respir. Dis. 137(4), 397 (1988).
33. A. M. Sciuto, P. T. Strickland, T. P. Kennedy, Y-L. Guo and G. H. Gurtner, Intratracheal administration of dibutyryl cAMP attenuates edema formation in phosgene-induced acute lung injury. J. Appl. Physiol. 80(1): 149-157 (1996).